• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drugs and the renin-angiotensin system in covid-19.

作者信息

Aronson Jeffrey K, Ferner Robin E

机构信息

Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

出版信息

BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.

DOI:10.1136/bmj.m1313
PMID:32241880
Abstract
摘要

相似文献

1
Drugs and the renin-angiotensin system in covid-19.新冠病毒肺炎中的药物与肾素-血管紧张素系统
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
2
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗？
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
3
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
4
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
5
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
6
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统阻滞剂在新型冠状病毒肺炎患者中的疗效：一项系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):335-337. doi: 10.1093/ehjcvp/pvaa074.
7
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.肾素-血管紧张素-醛固酮系统抑制剂治疗高血压患者可降低COVID-19死亡率：一项荟萃分析
Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.
8
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.在对COVID-19中的RAS阻断进行快速判断之前的可靠科学依据。
Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716. doi: 10.2215/CJN.03530320. Epub 2020 Mar 27.
9
The role of ACEIs/ARBs in COVID-19: Friend or foe?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂在2019冠状病毒病中的作用：是友还是敌？
Med Hypotheses. 2020 Sep;142:109810. doi: 10.1016/j.mehy.2020.109810. Epub 2020 May 5.
10
[The RAAS and SARS-CoV-2: A riddle to solve].[肾素-血管紧张素-醛固酮系统与新型冠状病毒2：待解之谜]
Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):169-175. doi: 10.1016/j.hipert.2020.05.005. Epub 2020 May 27.

引用本文的文献

1
Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.新冠病毒相关心血管疾病中的遗传与表观遗传交叉点：新见解与未来方向
Biomedicines. 2025 Feb 16;13(2):485. doi: 10.3390/biomedicines13020485.
2
Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.肾素-血管紧张素系统/血管紧张素转换酶2机制在2型糖尿病中增强新型冠状病毒肺炎易感性的作用
World J Diabetes. 2024 Apr 15;15(4):606-622. doi: 10.4239/wjd.v15.i4.606.
3
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy.
靶向宿主钙通道和病毒孔蛋白：一种有前景的治疗新冠病毒的策略。
Future Virol. 2023 Aug. doi: 10.2217/fvl-2022-0203. Epub 2023 Sep 11.
4
Preventive measures against the COVID-19 pandemic in Mexico: A cross-sectional study.墨西哥针对 COVID-19 大流行的预防措施：一项横断面研究。
Front Public Health. 2022 Oct 11;10:932010. doi: 10.3389/fpubh.2022.932010. eCollection 2022.
5
A Review: Highlighting the Links between Epigenetics, COVID-19 Infection, and Vitamin D.综述：强调表观遗传学、COVID-19 感染和维生素 D 之间的联系。
Int J Mol Sci. 2022 Oct 14;23(20):12292. doi: 10.3390/ijms232012292.
6
Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2.外泌体介导的信号转导通过人工 microRNA（amiRNA）：抑制 SARS-CoV-2 的潜在靶点。
Cell Signal. 2022 Jul;95:110334. doi: 10.1016/j.cellsig.2022.110334. Epub 2022 Apr 21.
7
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice.口服赖诺普利可提高健康雄性和雌性小鼠体内严重急性呼吸综合征冠状病毒2（SARS-CoV-2）受体血管紧张素转换酶2（ACE2）的组织水平。
Front Pharmacol. 2022 Mar 10;13:798349. doi: 10.3389/fphar.2022.798349. eCollection 2022.
8
An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction.关于新冠病毒发病机制与治疗复杂机制的最新综述：病毒直接损伤、肾素-血管紧张素系统失调、免疫系统紊乱及内皮功能障碍
Infect Disord Drug Targets. 2022;22(7):81-91. doi: 10.2174/1871526522666220321153712.
9
Cardiovascular System during SARS-CoV-2 Infection.心血管系统在 SARS-CoV-2 感染期间的变化。
Int J Environ Res Public Health. 2022 Jan 21;19(3):1184. doi: 10.3390/ijerph19031184.
10
Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study.RAAS抑制剂对COVID-19大流行期间ST段抬高型心肌梗死患者临床结局和死亡率的影响：一项多中心观察性研究
Front Cardiovasc Med. 2021 Dec 24;8:792804. doi: 10.3389/fcvm.2021.792804. eCollection 2021.